Article Versions Notes

Fernandez-Antunez C, Ryberg LA, Wang K, Pham LV, Mikkelsen LS, Fahnøe U, Hartmann KT, Jensen HE, Holmbeck K, Bukh J, et al. SARS-CoV-2 Remdesivir Exposure Leads to Different Evolutionary Pathways That Converge in Moderate Levels of Drug Resistance. Viruses. 2025; 17(8):1055. https://doi.org/10.3390/v17081055

Fernandez-Antunez, Carlota, Line A. Ryberg, Kuan Wang, Long V. Pham, Lotte S. Mikkelsen, Ulrik Fahnøe, Katrine T. Hartmann, Henrik E. Jensen, Kenn Holmbeck, Jens Bukh, and et al. 2025. "SARS-CoV-2 Remdesivir Exposure Leads to Different Evolutionary Pathways That Converge in Moderate Levels of Drug Resistance" Viruses 17, no. 8: 1055. https://doi.org/10.3390/v17081055

Fernandez-Antunez, C., Ryberg, L. A., Wang, K., Pham, L. V., Mikkelsen, L. S., Fahnøe, U., Hartmann, K. T., Jensen, H. E., Holmbeck, K., Bukh, J., & Ramirez, S. (2025). SARS-CoV-2 Remdesivir Exposure Leads to Different Evolutionary Pathways That Converge in Moderate Levels of Drug Resistance. Viruses, 17(8), 1055. https://doi.org/10.3390/v17081055